Related references
Note: Only part of the references are listed.Dose conversion ratio, comparative efficacy, and adverse events after switching from onabotulinum toxin A to abobotulinum toxin A for neurological conditions
Inci Sule Ozer et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2021)
Long-term adherence and response to botulinum toxin in different indications
John-Ih Lee et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Hemifacial spasm through the last three decades: From etiology to efficacy and safety of long-term botulinum toxin treatment
Yolanda Herrero-Infante et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2021)
Validation of a new hemifacial spasm grading questionnaire (HFS score) assessing clinical and quality of life parameters
Bettina Wabbels et al.
JOURNAL OF NEURAL TRANSMISSION (2021)
The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A
Subsai Kongsaengdao et al.
TOXINS (2021)
Real-world experience with botulinum toxin A for the treatment of hemifacial spasm: A study of 1138 injections
Samantha Anne S. Gutierrez et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2021)
Long-term stable efficacy of botulinum toxin A in facial movement disorders with no need for increasing dose
Samih Badarny et al.
MEDICINE (2021)
Spasm Freedom Following Microvascular Decompression for Hemifacial Spasm: Systematic Review and Meta-Analysis
Katherine Holste et al.
WORLD NEUROSURGERY (2020)
Switchover study ofonabotulinumtoxinAtoincobotulinumtoxinAfor facial dystonia
John C. Bladen et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)
Diagnosis of primary hemifacial spasm
J. -P. Lefaucheur et al.
NEUROCHIRURGIE (2018)
A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques
Praween Lolekha et al.
NEUROLOGICAL SCIENCES (2017)
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
Marco Pirazzini et al.
PHARMACOLOGICAL REVIEWS (2017)
Increasing the area and varying the dosage of Botulinum toxin a injections for effective treatment of hemifacial spasm
Won Joo Choe et al.
ACTA OTO-LARYNGOLOGICA (2016)
Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA Treatment
Mandar Jog et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2016)
Evaluation of concentrations of botulinum toxin A for the treatment of hemifacial spasm: a randomized double-blind crossover trial
Y. J. Li et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them
Mark Hallett
TOXICON (2015)
Current gaps in basic science knowledge of botulinum neurotoxin biological actions
Ornella Rossetto et al.
TOXICON (2015)
Long-term therapy of benign essential blepharospasm and facial hemispasm with botulinum toxin A: retrospective assessment of the clinical and quality of life impact in patients treated for more than 15 years
Hana Streitova et al.
ACTA NEUROLOGICA BELGICA (2014)
Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm
Osama H. Ababneh et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2014)
Botulinum neurotoxins: genetic, structural and mechanistic insights
Ornella Rossetto et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders
Mark Hallett et al.
TOXICON (2013)
Safety and effectiveness of microvascular decompression for treatment of hemifacial spasm: a systematic review
Larry E. Miller et al.
BRITISH JOURNAL OF NEUROSURGERY (2012)
Hemifacial spasm: clinical characteristics of 321 Indian patients
Amit Batla et al.
JOURNAL OF NEUROLOGY (2012)
Retrospective evaluation of the dose equivalence of Botox® and Dysport® in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story
Anna Rita Bentivoglio et al.
NEUROLOGICAL SCIENCES (2012)
Is It Always Necessary to Apply Botulinum Toxin into the Lower Facial Muscles in Hemifacial Spasm? A Randomized, Single-Blind, Crossover Trial
Beril Donmez Colakoglu et al.
EUROPEAN NEUROLOGY (2011)
The Many Faces of Hemifacial Spasm: Differential Diagnosis of Unilateral Facial Spasms
Toby C. Yaltho et al.
MOVEMENT DISORDERS (2011)
Comparison of two Different Formulations of Botulinum Toxin a for the Treatment of Blepharospasm and Hemifacial Spasm
Chuan-jie Wu et al.
TURKISH NEUROSURGERY (2011)
Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes
S. Cillino et al.
EYE (2010)
Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy
Monika Rudzinska et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Hemifacial spasm and reinnervation synkinesias: long-term treatment with either BotoxA® or DysportA®
Katja Kollewe et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Prospective, Randomized, Double-Blind Study, Comparing Botulinum Toxins Type A Botox and Prosigne for Blepharospasm and Hemifacial Spasm Treatment
Elizabeth Maria Aparecida Barasnevicius Quagliato et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm
A. R. Bentivoglio et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Routine use of Xeomin® in patients previously treated with Botox®: long term results
D. Dressler
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Bilateral hemifacial spasm: A series of 10 patients with literature review
Andre Carvalho Felicio et al.
PARKINSONISM & RELATED DISORDERS (2008)
Botulinum toxin type B (Myobloc®) in subjects with hemifacial spasm:: Results from an open-label, dose-escalation safety study
Richard M. Trosch et al.
MOVEMENT DISORDERS (2007)
Microvascular decompression for hemifacial spasm: postoperative neurologic follow-up and evaluation of life quality
K. Heuser et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm
Carlos R. M. Rieder et al.
CLINICAL NEUROPHARMACOLOGY (2007)
A comparative study of primary and secondary hemifacial spasm
C Colosimo et al.
ARCHIVES OF NEUROLOGY (2006)
Validation of a short disease specific quality of life scale for hemifacial spasm: correlation with SF-36
EK Tan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm
K Bihari
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Botulinum toxin A treatment for primary hemifacial spasm - A 10-year multicenter study
G Defazio et al.
ARCHIVES OF NEUROLOGY (2002)
Share Paper
